Asimov Company
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Investors
Investors Number:
9.0
Total Funding:
205000000.0
Technology:
['BioTech & HealthTech']
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Industry:
Medical BioTech
Founded Date:
2017-01-01
Headquarters:
Boston, Massachusetts, United States
Last Funding Date:
2023-01-05
Last Funding Type:
Series B
Investor Type:
hello@asimov.com
Funding Status:
Early Stage Venture